We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-6.88%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.39B
AUM Growth
-$1.88B
Cap. Flow
-$1.67B
Cap. Flow %
-49.21%
Top 10 Hldgs %
42.09%
Holding
110
New
24
Increased
17
Reduced
27
Closed
38

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$163M
2
NXPI icon
NXP Semiconductors
NXPI
+$72.5M
3
PTCT icon
PTC Therapeutics
PTCT
+$72M
4
CI icon
Cigna
CI
+$64.7M
5
SAGE
Sage Therapeutics
SAGE
+$62.5M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$217M
2
HUM icon
Humana
HUM
+$149M
3
ICUI icon
ICU Medical
ICUI
+$97.4M
4
BABA icon
Alibaba
BABA
+$84.2M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$83.1M

Sector Composition

Rank Sector Weight
1 Healthcare 59.59%
2 Technology 15.32%
3 Financials 1.11%
4 Communication Services 1.02%
5 Consumer Discretionary 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
26
HCA Healthcare
HCA
$90.6B
$50.2M 1.48%
416,733
-213,034
-34% -$27.5M
INTU icon
27
Intuit
INTU
$91.1B
$47.9M 1.41%
180,102
-37,645
-17% -$10.4M
GDDY icon
28
GoDaddy
GDDY
$13.9B
$47.8M 1.41%
723,756
-58,686
-8% -$3.98M
WDC icon
29
Western Digital
WDC
$159B
$47.5M 1.4%
+1,053,001
New +$44.9M
QURE icon
30
uniQure
QURE
$2.75B
$45.6M 1.35%
1,158,694
+983,940
+563% +$56.8M
SYK icon
31
Stryker
SYK
$135B
$45M 1.33%
207,887
-220,962
-52% -$47.4M
PBYI icon
32
Puma Biotechnology
PBYI
$398M
$39.7M 1.17%
3,689,538
+851,162
+30% +$9.19M
AERI
33
DELISTED
Aerie Pharmaceuticals
AERI
$35.2M 1.04%
+1,830,924
New +$41.9M
ICLR icon
34
Icon
ICLR
$13.7B
$34.9M 1.03%
237,175
+106,800
+82% +$16.4M
MSFT icon
35
Microsoft
MSFT
$2.9T
$34.8M 1.03%
250,603
-151,976
-38% -$20.9M
NVRO
36
DELISTED
NEVRO CORP.
NVRO
$34.1M 1.01%
396,270
-434,564
-52% -$32.9M
MRTX
37
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$33.6M 0.99%
+431,123
New +$40.5M
MKSI icon
38
MKS Inc
MKSI
$17.4B
$27.8M 0.82%
+301,611
New +$24.9M
AMD icon
39
Advanced Micro Devices
AMD
$700B
$25.8M 0.76%
+890,079
New +$27.9M
DERM
40
DELISTED
Dermira, Inc.
DERM
$24.5M 0.72%
3,829,536
-215,006
-5% -$1.8M
V icon
41
Visa
V
$701B
$23.1M 0.68%
+134,188
New +$23.9M
MCK icon
42
CALL
McKesson
MCK
$104B
$22.9M 0.68%
+167,400
New +$23.7M
CSII
43
DELISTED
Cardiovascular Systems, Inc.
CSII
$22.1M 0.65%
465,045
+39,730
+9% +$1.87M
COUP
44
DELISTED
Coupa Software Incorporated
COUP
$21.7M 0.64%
167,323
-19,612
-10% -$2.72M
INSP icon
45
Inspire Medical Systems
INSP
$1.47B
$21.4M 0.63%
350,870
+309,907
+757% +$20.4M
VYGR icon
46
Voyager Therapeutics
VYGR
$181M
$21.2M 0.63%
1,231,954
-885,434
-42% -$18.6M
TWTR
47
DELISTED
Twitter, Inc.
TWTR
$19.7M 0.58%
477,780
-810,247
-63% -$33.1M
PRNB
48
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$15.8M 0.47%
559,553
-34,963
-6% -$1.28M
LAB icon
49
Standard BioTools
LAB
$342M
$14.4M 0.43%
3,109,179
+1,732,922
+126% +$13.6M
CHRS icon
50
Coherus Oncology
CHRS
$217M
$14M 0.41%
689,825
-768,160
-53% -$15.3M
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q3 2019 Portfolio in Review

As of Q3 2019, PFM Health Sciences held 110 positions worth $3.39B, down 36% from $5.26B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

PFM Health Sciences withdrew a net $1.67B in Q3 2019, closing 38 positions and reducing 27 holdings. Its most notable exit was Humana, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 55% a quarter earlier, followed by Technology and Financials.

Against the trend, PFM Health Sciences opened a new position in Alexion Pharmaceuticals worth $142M.

  • PFM Health Sciences's largest Q3 2019 buy was Alexion Pharmaceuticals: 1,446,612 shares worth $142M.
  • PFM Health Sciences added most to uniQure in Q3 2019, an estimated $56.8M increase.
  • PFM Health Sciences's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $217M.
  • PFM Health Sciences fully exited Humana in Q3 2019, selling an estimated $149M.
  • PFM Health Sciences's ten largest holdings make up 42% of its $3.39B portfolio in Q3 2019.
  • PFM Health Sciences opened 24 new positions and closed 38 in Q3 2019.
  • PFM Health Sciences's portfolio value fell 36% quarter-over-quarter to $3.39B.

Based on PFM Health Sciences's 13F filing for Q3 2019, filed 14 Nov 2019.